Dean Y. Li - 29 Apr 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Executive VP & President, MRL
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Dean Y. Li
Issuer symbol
MRK
Transactions as of
29 Apr 2025
Transactions value $
$0
Form type
4
Filing time
01 May 2025, 18:04:29 UTC
Previous filing
03 Apr 2025
Next filing
23 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 80,181 29 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Award $0 +14,166 $0.000000 14,166 29 Apr 2025 Common Stock 14,166 Direct F2, F3
transaction MRK Stock Option (Right to Buy) Award $0 +64,481 $0.000000 64,481 29 Apr 2025 Common Stock 64,481 $84.71 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
F4 The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.